Bioavailability of Enasidenib (CC-90007) Sprinkle Formulation Relative to the Reference Tablet Formulation and Effect of Food on the Pharmacokinetics of Sprinkle Formulation in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 9, 2019

Primary Completion Date

November 27, 2019

Study Completion Date

December 9, 2019

Conditions

Healthy Volunteers

Interventions

DRUG

Enasidenib

Trial Locations (1)

PPD Development, LP, Austin